Spectrum bias in device trials, every validation cohort seems tidier than the one actually waiting in our clinics.
@dabishnhs.bsky.social
@dabishnhs.bsky.socialSpectrum bias in device trials, every validation cohort seems tidier than the one actually waiting in our clinics.
@cardiobeast.bsky.socialNew drug coated balloon just got FDA approval for angioplasty. Solid option when stenting isnt ideal. Less permanent hardware in the vessel. Good move.
@drhowardsmith.bsky.socialPomegranate May Boost Cardiac Function. Its byproduct, UroA, prevents heart muscle deterioration and helps prevent heart failure. Pomegranate May Boost Cardiac Function. #HeartFailure #Pomegranate #UrolithinA #HeartHealth #MedicalResearch
@imrpress.com❤️ Can biomarkers sharpen HFpEF risk stratification? A scoping review explores sST2 and Gal-3, highlighting their links with fibrosis, inflammation and poorer outcomes—and their potential as complementary biomarkers. #HFpEF #HeartFailure
@biomedicines.bsky.social🫀How can doctors tell if hospitalized heart failure patients are responding to treatment? This study explored whether estimated plasma volume variation, calculated from routine blood tests, could help assess treatment response #HeartFailure
www.mdpi.com/2227-9059/13...
@jcardfail.bsky.socialWhat makes JCF impactful? Ask the people behind it. 💜
Our Impact Factor has grown 48% since 2023, from 6.7 to 9.9. But our growth is about more than a number.
It reflects a global community advancing #HeartFailure research together.
@biomedicines.bsky.social🫀Heart failure, iron deficiency & inflammation are closely interconnected and drive disease progression. This review explores their complex relationship in older adults. 👵#HeartFailure
www.mdpi.com/2227-9059/13...
@talius2.bsky.social#Kidneydisease, #heartfailure or #death #risk climbs to 55% 10 years after #type 2 #diabetes diagnosis
Landmark diabetes study reveals the combined risk of heart failure, kidney disease, or death skyrockets to 55% within a decade of a type 2 diagnosis
scitechupdates.com/k...
@kill-bait.bsky.socialHeart Failure Prevalence Rises as Aging Population Faces Cardiometabolic Risks
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#heartfailure #publichealth #cardiometabolic
👇👇👇
@aoifecardiac.bsky.socialGP ears still catch what echo lists miss
@hollerdoc.bsky.socialwell now gE HealthCare's $945M play for Sofie, PET tracers for cardiac amyloid and sarcoid are a diagnostic holy grail for rural FP. Nearest PET scanner's two hours east.
medtechdive.com/news/ge-healthcare-to-acquire-s…
@cvia-journal.orgMeta analysis shows TTVI & OMT reduced mortality & #HeartFailure hospitalization vs OMT alone, but the benefit was observational; randomized trials were neutral, though #TricuspidRegurgitation severity & QoL improved. #medsky #Cardiology
#CVIA #OpenAccess: doi.org/10.15212/CVI...
@drsarahwh.bsky.socialFive participants. Either the FDA's fishing for proof decentralised trials can hit QMS standards, or quietly writing the SOP everyone else will copy. Probably both.
@jamacardiology.comAmong patients with #HeartFailure with reduced ejection fraction in Sri Lanka, a once-daily polypill improved composite guideline-directed medical therapy adherence vs usual care. ja.ma/4AKj9f8
@jamacardiology.com💬 Editorial: A once-daily #HeartFailure polypill improved adherence and reduced pill burden vs usual care in a randomized implementation trial in Sri Lanka.
@jamacardiology.comAmong patients hospitalized for #HeartFailure, most had multiple overlapping #CardiovascularKidneyMetabolic conditions, and increasing multimorbidity was associated with higher mortality and readmission risk.
@cardiologyadvisor.bsky.socialElevated baseline levels of interleukin-6 independently predicted an increased risk for incident #HeartFailure among patients with #type2diabetes and obesity.
https://www.thecardiologyadvisor.com/news/il-6-predicts-heart-failure-type-2-diabetes-obesity/
@aci-journal.medsky.socialNEW: Continuous Remote Patient Monitoring in Heart Failure Patients: The #HeartFailure Cascade Study: Phase II and III Outcomes www.thieme-connect.com/products/ejo...
#MedSky #CardioSky #RemoteMonitoring #HealthIT #DigitalHealth
@jamacardiology.com💬 Editorial: Global #HeartFailure prevalence has increased substantially, and better prevention of hypertension, ischemic heart disease, and rheumatic heart disease may help reduce future burden.
@jamacardiology.comGlobally, #HeartFailure affected an estimated 56 million people in 2023, with increasing burden largely associated with population growth and aging.
